Bonus Material-29_Lung Cancer Part I_Silvestri 25

Pdf Summary

This comprehensive review on lung cancer covers epidemiology, screening, diagnosis, staging, and management of solitary pulmonary nodules (SPNs), with insights from recent research and guidelines.<br /><br />Epidemiology highlights the significant burden in the US, with approximately 226,650 new lung cancer cases and 124,730 deaths projected for 2025. Tobacco exposure accounts for 80-90% of cases, with other risk factors including asbestos, radon, and COPD. Lung cancer primarily affects older adults (mean age ~70).<br /><br />Histologic subtypes differ in presentation and prognosis: squamous cell carcinoma is mostly central and smoking-related; adenocarcinoma is the most common subtype, frequently peripheral and seen increasingly in never-smokers; small cell carcinoma is central and highly metastatic. The former bronchoalveolar carcinoma subtype is a subset of adenocarcinoma with distinct clinical features.<br /><br />Screening via low-dose CT reduces lung cancer mortality by about 20% (NLST trial). The updated US Preventive Services Task Force criteria lowered the starting age from 55 to 50 and pack-years from 30 to 20, expanding eligibility.<br /><br />SPNs warrant careful evaluation using clinical predictors (age, smoking status, nodular features), imaging (CT edge characteristics, PET), and biopsy (CT-guided fine needle aspiration or bronchoscopy), with risk stratification to guide management ranging from serial CT surveillance to surgical excision.<br /><br />Lung cancer staging has evolved with the 8th/9th editions of the TNM system improving size, nodal (N), and metastatic (M) classifications, important for treatment planning. Small cell lung cancer employs a simpler limited vs extensive stage scheme.<br /><br />Operability assessment integrates tumor resectability and patient cardiopulmonary fitness. Pulmonary function tests (FEV1, DLCO) and exercise testing (6-minute walk, stair climbing, CPET) predict surgical risk and outcomes. Predicted postoperative values guide selection, with >60% ppoFEV1 and ppoDLCO considered low risk.<br /><br />Diagnosis can also use cytology of pleural fluid or biopsy of metastatic sites. Paraneoplastic syndromes such as hypercalcemia, SIADH, or paraneoplastic myasthenia gravis may occur.<br /><br />Overall, multidisciplinary evaluation and adherence to updated guidelines optimize early detection and management, improving survival chances in lung cancer patients.

Meta Tag

Concept Lung Cancer

Concept Lung Cancer Screening

Concept Solitary Pulmonary Nodule

Concept Lung Cancer Staging

Concept Tobacco Use

Keywords

lung cancer

epidemiology

low-dose CT screening

solitary pulmonary nodules

TNM staging

adenocarcinoma

squamous cell carcinoma

small cell carcinoma

pulmonary function tests

multidisciplinary management

Lung Cancer

Lung Cancer Screening

Solitary Pulmonary Nodule

Lung Cancer Staging

Tobacco Use